Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP844593.RA0fMZp0YbpwbqGZcK40p9LELly2wGA7BViX3ERc6gRqA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP844593.RA0fMZp0YbpwbqGZcK40p9LELly2wGA7BViX3ERc6gRqA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP844593.RA0fMZp0YbpwbqGZcK40p9LELly2wGA7BViX3ERc6gRqA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP844593.RA0fMZp0YbpwbqGZcK40p9LELly2wGA7BViX3ERc6gRqA130_provenance.
- NP844593.RA0fMZp0YbpwbqGZcK40p9LELly2wGA7BViX3ERc6gRqA130_assertion description "[Therefore, TAP expression restores both antigen presentation and immunogenicity in A375 melanoma cells and concomitantly increases IL-12 and IFN-gamma production in tumor antigen-specific CTLs; TAP should be considered as a part of the immunotherapies for MM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP844593.RA0fMZp0YbpwbqGZcK40p9LELly2wGA7BViX3ERc6gRqA130_provenance.
- NP844593.RA0fMZp0YbpwbqGZcK40p9LELly2wGA7BViX3ERc6gRqA130_assertion evidence source_evidence_literature NP844593.RA0fMZp0YbpwbqGZcK40p9LELly2wGA7BViX3ERc6gRqA130_provenance.
- NP844593.RA0fMZp0YbpwbqGZcK40p9LELly2wGA7BViX3ERc6gRqA130_assertion SIO_000772 18385764 NP844593.RA0fMZp0YbpwbqGZcK40p9LELly2wGA7BViX3ERc6gRqA130_provenance.
- NP844593.RA0fMZp0YbpwbqGZcK40p9LELly2wGA7BViX3ERc6gRqA130_assertion wasDerivedFrom befree-20150227 NP844593.RA0fMZp0YbpwbqGZcK40p9LELly2wGA7BViX3ERc6gRqA130_provenance.
- NP844593.RA0fMZp0YbpwbqGZcK40p9LELly2wGA7BViX3ERc6gRqA130_assertion wasGeneratedBy ECO_0000203 NP844593.RA0fMZp0YbpwbqGZcK40p9LELly2wGA7BViX3ERc6gRqA130_provenance.
- befree-20150227 importedOn "2015-02-27" NP844593.RA0fMZp0YbpwbqGZcK40p9LELly2wGA7BViX3ERc6gRqA130_provenance.